Liposomal Doxorubicin/Rituximab Regimen

Preferred Label : Liposomal Doxorubicin/Rituximab Regimen;

NCIt synonyms : Doxil/Rituxan; Rituximab/Doxorubicin Liposomal; Liposomal Doxorubicin/Rituximab; Liposomal Doxorubicin-Rituximab; Doxil/Rituximab;

NCIt definition : A regimen consisting of liposomal doxorubicin and rituximab that may be used in the treatment of Castleman disease.;

NCI Metathesaurus CUI : CL1926311;

Détails

Origin ID

C204008;

UMLS CUI

C5909537;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Pegylated Liposomal Doxorubicin Hydrochloride [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients